This accredited digital CME program will deliver guideline‑aligned pathway for early breast cancer, covering epidemiology and hereditary risk, evidence‑based screening with AI integration, diagnostic and axillary staging, the evolution of surgery and radiotherapy, neoadjuvant and adjuvant systemic therapy (including CDK4/6), supportive care for special populations with psychological and nutritional components, and precision targeting with future directions, culminating in structured management p...